After losing her fight to have her convictions overturned for her role in Jeffrey Epstein’s sex trafficking operation, but at least getting 10 years knocked off her potential maximum sentence, Ghislaine Maxwell was moved out of solitary confinement last week.
A federal judge has blocked special counsel John Durham from introducing evidence he contends will show former Hillary Clinton campaign attorney Michael Sussmann acted as part of a “joint venture” to taint former President Trump by linking him to Russia.
Three Arizona parents have filed a lawsuit claiming an education board member for the Scottsdale Unified School District (SUSD) kept a dossier on them to silence criticism of district policies regarding COVID-19 and other subjects.
Sixteen truckers who participated in the recent People's Convoy in the county’s capitol region are suing the District of Columbia for blockades they argue prevented them from exercising their "constitutionally protected right to free speech" on the streets of Washington, D.C.
Special counsel John Durham is ramping up his efforts to get a judge to review documents shielded by attorney-client privilege claims from Hillary Clinton's 2016 campaign and the Democratic National Committee.
Judicial Watch today announced it received 466 pages of records from the U.S. Department of Health and Human Services (HHS) regarding biodistribution studies and related data for the COVID-19 vaccines that show a key component of the vaccines developed by Pfizer/BioNTech, lipid nanoparticles (LNPs), were found outside the injection site, mainly the liver, adrenal glands, spleen and ovaries of test animals, eight to 48 hours after injection.
Former Minneapolis police officer Derek Chauvin is appealing his murder conviction on the grounds that the jury was swayed by publicity and protesters.
Pfizer on Tuesday said results of Phase 2 clinical trials of its experimental Lyme disease vaccine delivered “positive” results, including among pediatric trial participants.
The U.S. Food and Drug Administration (FDA) on Monday approved the use of the antiviral therapy, remdesivir, to treat COVID-19 in infants four weeks and older.
